Overview

This trial is unknown status.

Condition substance-related disorders
Treatment behavior therapy
Phase phase 2
Sponsor National Institute on Drug Abuse (NIDA)
Start date July 2001
End date June 2002
Trial size 50 participants
Trial identifier NCT00033124, NCT00024739, NIDA-CTO-0009-1

Summary

The purpose of this study is to examine behavioral treatment for methamphetamine dependence.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Primary purpose treatment

Primary Outcomes

Measure
Withdrawal symptoms
time frame:
New Use algorithm
time frame:

Eligibility Criteria

Male or female participants from 18 years up to 99 years old.

Inclusion Criteria: Male or Female at least 18 yrs of age; DSM-4 diagnosis of methamphetamine (METH) dependence; be willing to comply with study procedures; verbalize understanding of consent and provide written consent and willingness to complete study procedures; be seeking treatment for METH dependence. Exclusion Criteria: Additional criteria available during screening at the site.

Additional Information

Official title Behavioral Trial for the Treatment of Methamphetamine Dependence
Principal investigator Richard Rawson, Ph.D.
Description To characterize meth. withdrawal symptoms using a multidimensional withdrawal questionnaire; to field test and investigate the effect of using an algorithm developed for discriminating between new use and residual carry-over of meth metabolites in urine and to evaluate the treatment response of meth. users to participation in the thrice weekly psychosocial protocol to be used as a "platform" in future pharmacotherapy trials.
Trial information was received from ClinicalTrials.gov and was last updated in January 2017.
Information provided to ClinicalTrials.gov by National Institute on Drug Abuse (NIDA).